HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
This discussion paper addresses the safety of HIV cure studies, particularly those involving stopping antiretroviral therapy, known as an analytic treatment interruption (ATI) in the context of the SARS-CoV-2 pandemic. More than 30 studies listed on ClinicalTrials.gov include an ATI and many others...
Saved in:
Main Authors: | S. Fidler (Author), S. Lewin (Author), S. Deeks (Author), O.S. Sogaard (Author), L. Vandekerckhove (Author), S. Collins (Author), D. Kelly (Author), J. Singh (Author), M. Caskey (Author), J. Frater (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom
by: Ming J. Lee, et al.
Published: (2023) -
Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
by: Evelyn Y. Bonney, et al.
Published: (2021) -
Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
by: Jillian SY. Lau, et al.
Published: (2021) -
Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
by: Samual A. Garner, et al.
Published: (2017) -
Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium
by: C. Rokx, et al.
Published: (2021)